FDA reversals on UniQure, Moderna approvals worry investors

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from…

Read More

Life Time, Planet Fitness earnings show K-shaped economy

Two of the largest U.S. gym operators delivered the same headline in their latest earnings reports: strong growth. But beneath the surface, Life Time Group Holdings and Planet Fitness told very different stories about the American consumer. They highlighted a widening divide between higher-income households that continue to spend freely and more price-sensitive consumers who…

Read More

Kennedy defends Trump glyphosate order; MAHA erupts

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. speaks, announcing new nutrition policies during a press conference at the Department of Health and Human Services in Washington, D.C., U.S., Jan. 8, 2026. Jonathan Ernst | Reuters Secretary of Health and Human Services Robert F. Kennedy Jr. defended President Donald Trump‘s executive order…

Read More